JP2012526094A5 - - Google Patents

Download PDF

Info

Publication number
JP2012526094A5
JP2012526094A5 JP2012509111A JP2012509111A JP2012526094A5 JP 2012526094 A5 JP2012526094 A5 JP 2012526094A5 JP 2012509111 A JP2012509111 A JP 2012509111A JP 2012509111 A JP2012509111 A JP 2012509111A JP 2012526094 A5 JP2012526094 A5 JP 2012526094A5
Authority
JP
Japan
Prior art keywords
group
compound according
lipid compound
lipid
icosa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012509111A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012526094A (ja
JP5843755B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/001251 external-priority patent/WO2010128401A1/en
Publication of JP2012526094A publication Critical patent/JP2012526094A/ja
Publication of JP2012526094A5 publication Critical patent/JP2012526094A5/ja
Application granted granted Critical
Publication of JP5843755B2 publication Critical patent/JP5843755B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012509111A 2009-05-08 2010-05-07 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸 Active JP5843755B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17650309P 2009-05-08 2009-05-08
US61/176,503 2009-05-08
PCT/IB2010/001251 WO2010128401A1 (en) 2009-05-08 2010-05-07 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015151385A Division JP2016026146A (ja) 2009-05-08 2015-07-31 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸

Publications (3)

Publication Number Publication Date
JP2012526094A JP2012526094A (ja) 2012-10-25
JP2012526094A5 true JP2012526094A5 (enExample) 2013-06-20
JP5843755B2 JP5843755B2 (ja) 2016-01-13

Family

ID=43050039

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012509111A Active JP5843755B2 (ja) 2009-05-08 2010-05-07 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸
JP2015151385A Pending JP2016026146A (ja) 2009-05-08 2015-07-31 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015151385A Pending JP2016026146A (ja) 2009-05-08 2015-07-31 心血管性、代謝性および炎症性疾患領域に関する疾患の処置のための多価不飽和脂肪酸

Country Status (29)

Country Link
US (2) US8735436B2 (enExample)
EP (1) EP2427415B1 (enExample)
JP (2) JP5843755B2 (enExample)
KR (1) KR101783817B1 (enExample)
CN (1) CN102459142B (enExample)
AR (2) AR078507A1 (enExample)
AU (1) AU2010244136B2 (enExample)
BR (1) BRPI1015120B8 (enExample)
CA (1) CA2760877C (enExample)
CL (1) CL2011002745A1 (enExample)
CO (1) CO6430454A2 (enExample)
DK (1) DK2427415T3 (enExample)
EA (1) EA021177B1 (enExample)
ES (1) ES2726765T3 (enExample)
HR (1) HRP20190732T1 (enExample)
IL (1) IL216171A (enExample)
MA (1) MA33341B1 (enExample)
MX (2) MX366137B (enExample)
MY (1) MY165292A (enExample)
NZ (2) NZ618734A (enExample)
PH (1) PH12015500930B1 (enExample)
PL (1) PL2427415T3 (enExample)
PT (1) PT2427415T (enExample)
SG (1) SG175401A1 (enExample)
TR (1) TR201905768T4 (enExample)
TW (1) TWI558395B (enExample)
UA (1) UA109528C2 (enExample)
WO (1) WO2010128401A1 (enExample)
ZA (2) ZA201108163B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2217224B1 (en) 2007-11-09 2019-05-08 Basf As Lipid compounds for use in cosmetic products, as food supplement or as a medicament
RU2504373C2 (ru) 2008-03-26 2014-01-20 ОРАМЕД Лтд. Способы и композиции для перорального введения протеинов
EP2147910A1 (en) * 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
HRP20190732T1 (hr) 2009-05-08 2019-06-14 Basf As Polinezasićene masne kiseline za liječenje bolesti povezanih s kardiovaskularnim, metaboličkim i upalnim područjima bolesti
AP3082A (en) 2009-10-30 2015-01-31 Tharos Ltd Solvent-free process for obtaining phospholipids and neutral enriched krill oils
GB201014633D0 (en) 2010-09-02 2010-10-13 Avexxin As Rheumatoid arthritis treatment
SG10201509127YA (en) * 2010-11-05 2015-12-30 Pronova Biopharma Norge As Methods of treatment using lipid compounds
WO2014083528A2 (en) * 2012-12-02 2014-06-05 Mahesh Kandula Compositions and methods for the treatment of cardiovascular diseases and lipid disorders
EP2941267B1 (en) 2013-01-03 2022-11-16 Oramed Ltd. Compositions for use in treating nafld
PL2961727T3 (pl) * 2013-02-28 2017-06-30 Pronova Biopharma Norge As Sposób wytwarzania kwasu 2-((5Z,8Z, 11Z,14Z,17Z)-ejkoza-5,8,11,14,17-pentaenyloksy)butanowego
KR102213143B1 (ko) 2013-02-28 2021-02-08 바스프 에이에스 지방질 화합물, 트리글리세리드 및 계면활성제를 포함하는 조성물 및 이를 이용하는 방법
GB201409363D0 (en) 2014-05-27 2014-07-09 Avexxin As Skin cancer treatment
JP7341916B2 (ja) * 2015-04-01 2023-09-11 ビーエーエスエフ エーエス アポｃ３を低下させるためのチアオキソ化合物の使用
US20180110747A1 (en) * 2015-04-01 2018-04-26 Pronova Biopharma Norge As Use of thia oxo compounds for lowering apo c3
CN107530306A (zh) 2015-04-28 2018-01-02 普罗诺瓦生物医药挪威公司 结构增强的含硫脂肪酸在预防和/或治疗非酒精性脂肪性肝炎中的用途
GB201521085D0 (en) * 2015-11-30 2016-01-13 Biozep As Use
GB201604316D0 (en) 2016-03-14 2016-04-27 Avexxin As Combination therapy
US11351127B2 (en) 2016-09-21 2022-06-07 Avexxin As Pharmaceutical composition
EP4234035A3 (en) 2017-05-16 2023-11-15 Ability Pharmaceuticals S.A. A pharmaceutical combination for the treatment of a cancer
AU2018354090B2 (en) * 2017-10-23 2024-10-24 Epitracker, Inc. Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome
ES2996688T3 (en) 2017-12-06 2025-02-13 Basf As Fatty acid derivatives for treating non-alcoholic steatohepatitis
JP7492459B2 (ja) * 2018-05-16 2024-05-29 エピトラッカー インコーポレイテッド 加齢に関連する状態の診断及び治療のための組成物及び方法
AU2019274431B2 (en) 2018-05-23 2025-03-13 Epitracker, Inc. Compositions and methods for diagnosis and treatment of conditions related to the quality of aging and longevity
AU2019274203B2 (en) * 2018-05-23 2025-01-02 Basf As Structurally modified fatty acids for improving glycemic control and treating inflammatory bowel disease
SG11202103011YA (en) * 2018-10-11 2021-04-29 Basf As Aromatic compounds and pharmaceutical uses thereof
WO2020146263A1 (en) 2019-01-09 2020-07-16 Epitracker, Inc. Compositions and methods for diagnosis and treatment of neurodegenerative diseases
JP7404382B2 (ja) 2019-03-04 2023-12-25 エピトラッカー インコーポレイテッド 脂肪酸アナログ、ならびに認知機能障害、行動症状および慢性疼痛の処置におけるそれらの使用
US20220340561A1 (en) 2019-07-29 2022-10-27 Heparegenix Gmbh Heteroaryl-substituted pyrazolo-pyridine protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
JP7639008B2 (ja) 2020-01-15 2025-03-04 ヘパリジェニックス ゲーエムベーハー 肝再生促進又は肝細胞死の抑制もしくは防止のためのプロテインキナーゼ阻害剤
CN116829139A (zh) 2020-12-22 2023-09-29 北海医疗私人有限公司 用于治疗非酒精性脂肪性肝炎的包含含氧的结构增强的脂肪酸的联合治疗剂
US12370166B2 (en) 2021-11-03 2025-07-29 Epitracker, Inc. Pentadecanoylcarnitine for treatment of conditions related to the quality of aging and longevity

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909554A (en) 1956-07-23 1959-10-20 Monsanto Chemicals Process for the manufacture of (alkylmercapto) alkyl sulfates
GB1038723A (enExample) 1962-03-26
US4040781A (en) 1974-06-06 1977-08-09 Lever Brothers Company Novel 2-(alkylsulfinyl)ethyl sulfates and compositions employing same
US4032564A (en) * 1974-09-09 1977-06-28 Zoecon Corporation Esters of cyclopropylalkanols
GB1523276A (en) 1974-09-20 1978-08-31 Lafon Labor Sulphur-containing amino compounds
US4009211A (en) 1975-07-29 1977-02-22 Gulf Research & Development Company Beta,beta-dialkylethylmercaptoethoxylate as new compounds
US4209410A (en) 1976-04-28 1980-06-24 Phillips Petroleum Company Lubricants
EP0002007B1 (de) 1977-11-11 1982-07-28 Ciba-Geigy Ag Neue Pyridindicarbonsäureesterderivate und ihre Gemische mit metallhaltigen Stabilisatoren sowie ihre Verwendung zur Stabilisierung von chlorhaltigen Thermoplasten
JPS5570841A (en) 1978-11-24 1980-05-28 Konishiroku Photo Ind Co Ltd Forming method of dye image
US4368190A (en) 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
DE3164332D1 (en) 1980-10-21 1984-07-26 Boehringer Mannheim Gmbh Phospholipids that contain sulphur, process for their preparation and medicines containing these compounds
US4411808A (en) 1982-08-04 1983-10-25 Exxon Research & Engineering Co. Multifunctional additive for power transmission shift fluids
JPS6176438A (ja) * 1984-09-20 1986-04-18 Canon Inc 乳酸誘導体
US4775223A (en) * 1984-09-20 1988-10-04 Canon Kabushiki Kaisha Lactic acid derivative, liquid crystal composition containing same and liquid crystal device
CA2010000A1 (en) 1989-04-07 1990-10-07 Paul B. Merkel Photographic recording material containing a cyan dye-forming coupler
JPH0451149A (ja) 1990-06-19 1992-02-19 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
FR2663928B1 (fr) 1990-06-27 1994-04-08 Norsolor Nouveaux composes acryliques soufres, un procede pour leur preparation et leur application a la synthese de nouveaux polymeres.
EP0487809A1 (en) 1990-11-28 1992-06-03 Monsanto Europe S.A./N.V. Rubber compositions having improved processability and improved rubber-vulcanisate properties
JPH0543529A (ja) 1991-08-10 1993-02-23 Taisho Pharmaceut Co Ltd アルカンアミドアンモニウム化合物
JP2755279B2 (ja) 1992-03-19 1998-05-20 三井化学株式会社 熱可塑性樹脂組成物およびその成形体
JP2793458B2 (ja) 1992-03-19 1998-09-03 三井化学株式会社 コネクター用ポリアミド系樹脂組成物およびコネクター
ATE226437T1 (de) 1993-06-10 2002-11-15 Univ Wake Forest (phospho)lipide zum bekämpfen einer hepatitis b- infektion
JP3110918B2 (ja) 1993-06-18 2000-11-20 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
US5523430A (en) * 1994-04-14 1996-06-04 Bristol-Myers Squibb Company Protein farnesyl transferase inhibitors
GB2290789B (en) 1994-07-01 1998-09-16 Ciba Geigy Ag Titanium and zirconium complexes of carboxylic acids as corrosion inhibitors
EP0869941B1 (en) 1994-10-13 2001-12-12 Peptech Limited Modified polyunsaturated fatty acids
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
FR2741619B1 (fr) * 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
WO1997038688A1 (en) * 1996-04-12 1997-10-23 Peptide Technology Pty. Limited Methods of treating immunopathologies using polyunsaturated fattyacids
US6060515A (en) * 1997-01-24 2000-05-09 The Regents Of The University Of California Treatment of skin conditions by use of PPARα activators
PL334840A1 (en) * 1997-01-24 2000-03-27 Univ California Application of fxr, pparalpha and lxralpha activators in order to restore the barrier function, to stimulate epithelium differentation and to inhibit proliferation
AU4806497A (en) * 1997-10-01 1999-04-23 Procter & Gamble Company, The Glyoxylic compound comprising one or more active ingredient
JPH11180929A (ja) 1997-12-19 1999-07-06 Asahi Glass Co Ltd エステル誘導体
WO1999058120A1 (en) 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
FR2786187B1 (fr) 1998-11-19 2001-11-09 Univ Paris Curie Composes du type 2-acylamino-2-deoxy-glucono-1,5-lactone, procede d'obtention, compositions les comportant et utilisations
FR2792312B1 (fr) 1999-04-15 2001-06-08 Oreal Composes (poly)thia-alcynoiques et leurs derives, compositions les comprenant et leur utilisation
US6723717B1 (en) 1999-06-01 2004-04-20 The University Of Texas Southwestern Medical Center Sulfur-containing thyroxane derivatives and their use as hair growth promotors
AR018472A1 (es) 1999-06-01 2001-11-14 Procter & Gamble Compuesto, composicion y metodo para el tratamiento de la perdida de cabello
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
US7144906B2 (en) * 2000-05-26 2006-12-05 Nippon Shinyaku Co., Ltd. Heterocyclic compounds
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
FR2828487B1 (fr) 2001-08-09 2005-05-27 Genfit S A Nouveaux composes derives d'acides gras, preparation et utilisations
WO2003059316A1 (en) 2001-12-21 2003-07-24 3M Innovative Properties Company Medicinal aerosol formulations comprising ion pair complexes
GB2383355A (en) 2001-12-22 2003-06-25 Schlumberger Holdings An aqueous viscoelastic fluid containing hydrophobically modified polymer and viscoelastic surfactant
CN100392108C (zh) 2002-01-31 2008-06-04 Tfl皮革技术有限责任公司 组合物及其用途
AU2003251518B2 (en) 2002-06-13 2009-07-02 New York University Synthetic C-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
FR2845991B1 (fr) 2002-10-16 2005-02-04 Pf Medicament Derives d'alpha-phenyl acetanilides et leur application en therapeutique humaine
US8372430B2 (en) 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
EP1600438A4 (en) 2003-02-28 2007-05-02 Kaneka Corp METHODS FOR PRODUCING OPTICALLY ACTIVE COMPOUNDS COMPRISING SUBSTITUENTS IN POSITION 2
DE10326303A1 (de) 2003-06-11 2004-12-30 Celares Gmbh Reagenzien zur Modifikation von Biopharmazeutika, deren Herstellung und Anwendung
CA2554735A1 (en) * 2004-01-30 2005-08-11 Peplin Biolipids Pty Ltd Therapeutic and carrier molecules
JP4563114B2 (ja) 2004-08-30 2010-10-13 出光興産株式会社 潤滑剤用添加剤
WO2006109491A1 (ja) 2005-03-31 2006-10-19 Yamaguchi University 波力エネルギー変換装置
WO2006117664A1 (en) * 2005-05-04 2006-11-09 Pronova Biopharma Norge As New dha derivatives and their use as medicaments
CN101213281B (zh) * 2005-05-04 2013-03-13 普罗诺瓦生物医药挪威公司 新的dha衍生物及其作为药物的用途
US20070167529A1 (en) 2006-01-17 2007-07-19 Walton Rebecca A Antimicrobial compositions for treating fabrics and surfaces
EP2004169B1 (en) 2006-04-12 2012-08-08 Unilever PLC Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin
EP1849449A1 (en) 2006-04-26 2007-10-31 3M Innovative Properties Company Filler containing composition and process for production and use thereof
US7763607B2 (en) 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
WO2007133653A2 (en) 2006-05-09 2007-11-22 Hemaquest Pharmaceuticals, Inc. Methods for treating blood disorders
CN101535238A (zh) 2006-11-01 2009-09-16 普罗诺瓦生物医药挪威公司 作为过氧化物酶体增生物激活受体(PPAR)的活化剂或调节剂的α-取代的ω-3脂质
WO2008053340A1 (en) 2006-11-03 2008-05-08 Pronova Biopharma Norge As A combination product comprising at least one lipid substituted in the alpha position and at least one hypoglycemic agent
CN101225064A (zh) 2007-01-19 2008-07-23 上海汇瑞生物科技有限公司 一种制备β-硫杂-α-烷基脂肪酸的新方法
DE102007017179A1 (de) * 2007-04-12 2008-10-23 Clariant International Ltd. Verfahren zur Herstellung von Alkylpolyglykolcarbonsäuren und Polyglykoldicarbonsäuren mittels Direktoxidation
US8604004B2 (en) * 2007-10-04 2013-12-10 President And Fellows Of Harvard College Moenomycin analogs, methods of synthesis, and uses thereof
JP5575651B2 (ja) 2007-10-31 2014-08-20 プロノヴァ バイオファーマ ノルゲ アーエス 新規のｄｈａ誘導体およびその医薬品としての用途
EP2217224B1 (en) 2007-11-09 2019-05-08 Basf As Lipid compounds for use in cosmetic products, as food supplement or as a medicament
WO2009149496A1 (en) 2008-06-10 2009-12-17 Central Northern Adelaide Health Service Treatment of diabetes and complications thereof and related disorders
FR2933006B1 (fr) 2008-06-27 2010-08-20 Inst Francais Du Petrole Solution absorbante contenant un inhibiteur de degradation soufre a groupement carboxyle et methode pour limiter la degradation d'une solution absorbante
DK2315740T3 (en) 2008-07-08 2018-01-08 Catabasis Pharmaceuticals Inc Fatty Acid Acetylated Salicylates and Their Uses
EP2147910A1 (en) * 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
HRP20190732T1 (hr) 2009-05-08 2019-06-14 Basf As Polinezasićene masne kiseline za liječenje bolesti povezanih s kardiovaskularnim, metaboličkim i upalnim područjima bolesti
US8304551B2 (en) 2009-09-01 2012-11-06 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
CN102822141A (zh) 2010-01-20 2012-12-12 普罗诺瓦生物医药挪威公司 水杨酸脂肪酸衍生物
SG10201509127YA (en) 2010-11-05 2015-12-30 Pronova Biopharma Norge As Methods of treatment using lipid compounds
WO2012115695A1 (en) 2011-02-25 2012-08-30 Catabasis Pharmaceuticals, Inc. Bis-fatty acid conjugates and their uses
WO2013016531A2 (en) 2011-07-26 2013-01-31 Purdue Research Foundation Compounds and methods for use in treating neoplasia and cancer

Similar Documents

Publication Publication Date Title
JP2012526094A5 (enExample)
HRP20190732T1 (hr) Polinezasićene masne kiseline za liječenje bolesti povezanih s kardiovaskularnim, metaboličkim i upalnim područjima bolesti
TWI699354B (zh) 陽離子性脂質
JP6896019B2 (ja) 脂質化合物、トリグリセリドおよび界面活性剤を含む組成物、ならびにその使用方法
JP2014505017A5 (enExample)
JP2004526745A5 (enExample)
JP2007509055A5 (enExample)
JP2018515463A5 (enExample)
WO2011089529A4 (en) Salicylate fatty acid derivatives
KR102265409B1 (ko) 지질 화합물을 이용한 치료방법
JP2009530398A5 (enExample)
JP6261011B2 (ja) 眼疾患処置薬
JP5552314B2 (ja) 新規脂質化合物
JP2011503057A5 (enExample)
IL318963A (en) Compositions comprising 15-hydroxy-eicosapentaenoic acid and methods of using them
JP2024511208A (ja) 治療薬のバイオアベイラビリティを改善した組成物
KR20140099492A (ko) 삼환식 화합물, 이를 포함하는 조성물 및 그의 용도
JP2018510206A5 (enExample)
RU2017137960A (ru) Применение тиаоксосоединений для уменьшения содержания аро сз
JP2006509038A5 (enExample)
JP6093015B2 (ja) 改良された流動性を有する医薬組成物、薬剤、並びに同一物を製造及び使用するための方法
JP2013529686A5 (enExample)
US9358217B2 (en) Methods for reducing triglyceride, total cholesterol and low density lipoprotein blood levels
JP2013503876A (ja) インジブリンに関する薬学的組成物
EP2607367A1 (en) Glycerol phenyl butyrate derivatives